Viewing Study NCT00003928


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-03-09 @ 10:49 AM
Study NCT ID: NCT00003928
Status: COMPLETED
Last Update Posted: 2010-06-11
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CWRU3897
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Scot C. Remick, MD
Old Organization: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Collaborators

Collaborators

Name Class View
None NIH View